A multidimensional strategy to detect polypharmacological targets in the absence of structural and sequence homology.
Conventional drug design embraces the "one gene, one drug, one disease" philosophy. Polypharmacology, which focuses on multi-target drugs, has emerged as a new paradigm in drug discovery. The rational design of drugs that act via polypharmacological mechanisms can produce compounds that ex...
Main Authors: | Jacob D Durrant, Rommie E Amaro, Lei Xie, Michael D Urbaniak, Michael A J Ferguson, Antti Haapalainen, Zhijun Chen, Anne Marie Di Guilmi, Frank Wunder, Philip E Bourne, J Andrew McCammon |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2010-01-01
|
Series: | PLoS Computational Biology |
Online Access: | http://europepmc.org/articles/PMC2799658?pdf=render |
Similar Items
-
Functional and structural insights revealed by molecular dynamics simulations of an essential RNA editing ligase in Trypanosoma brucei.
by: Rommie E Amaro, et al.
Published: (2007-11-01) -
The Mycobacterium tuberculosis drugome and its polypharmacological implications.
by: Sarah L Kinnings, et al.
Published: (2010-11-01) -
The Polypharmacological Effects of Cannabidiol
by: Jorge Castillo-Arellano, et al.
Published: (2023-04-01) -
Computational polypharmacology comes of age
by: Giulio eRastelli, et al.
Published: (2015-07-01) -
Molecular dynamics simulations and drug discovery
by: Durrant Jacob D, et al.
Published: (2011-10-01)